August 9, 2023

IAVI Annual Report 2022

Throughout 2022, IAVI continued to forge new and build on existing partnerships with governments, academia, industry, and other scientific consortia globally that advance vaccine and antibody candidates from concept to clinic. Our socio-behavioral research and global access initiatives support product development that is rooted in and informed by the realities of communities where disease burden is the greatest. Together with our network of clinical research center partners in Africa and India, we conducted clinical trials, strengthened in-country research capacity, and supported the training and education of the next generation of scientists and advocates.

Read the full 2022 Annual Report here: